A Drug Interaction Study With Albiglutide and Warfarin
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 6/23/2017 |
| Start Date: | June 4, 2010 |
| End Date: | September 9, 2010 |
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Warfarin When Coadministered With Albiglutide in Healthy Adult Subjects
This open-label study evaluates the pharmacokinetics of warfarin when coadministered with
albiglutide in healthy adult subjects. The primary objective is to assess the effect of
albiglutide doses on the pharmacokinetics of warfarin.
albiglutide in healthy adult subjects. The primary objective is to assess the effect of
albiglutide doses on the pharmacokinetics of warfarin.
This Phase I open-label study evaluates the pharmacokinetics of warfarin when coadministered
with albiglutide in healthy adult subjects. The primary objective is to assess the effect of
albiglutide doses on the pharmacokinetics of warfarin.
with albiglutide in healthy adult subjects. The primary objective is to assess the effect of
albiglutide doses on the pharmacokinetics of warfarin.
Inclusion Criteria:
- male healthy volunteers in good health
- no clinically significant diseases or clinically significant abnormal laboratory
values
- body mass index (BMI) is >/=18 kg and ≤30 kg/m2
- nonsmoker
Exclusion Criteria:
- positive test results for hepatitis B, hepatitis C or human immunodeficiency virus
(HIV)
- any clinically relevant abnormality
- history of any anaphylactic reaction to any drug
- history of significant cardiovascular or pulmonary dysfunction
- history of excessive bleeding
- current or chronic history of liver disease
- history of alcohol or substance abuse
- history of thyroid disease or dysfunction
- history of gastrointestinal surgery or disease
- history of pancreatitis
- previously received any GLP-1 mimetic compound (e.g., exenatide)
We found this trial at
1
site
Click here to add this to my saved trials
